Brussels Authorizes Pfizer’s Omicron XBB.1.5 Variant Vaccine: Latest Updates and Information
Brussels authorizes the adapted vaccine against Pfizer’s Omicron XBB.1.5 variant Following the positive recommendation issued this week by the European Medicines Agency (EMA in its acronym in English), the European Comission has authorized this Friday the marketing of the new vaccine adapted against the XBB.1.5 variant of covid19 developed by the BioNTech-Pfizer laboratory. This is … Read more